Research venture capital firms in China by matching your operating market, technical thesis and financing milestone to the relevant investment team.
This guide compares 18 China-connected routes: 17 venture investors and one clearly labeled investment-backed accelerator. Some managers describe cross-border or regional activity; a China office, a past portfolio company or an accelerator cohort is not automatic evidence of company eligibility.
Choose the right China investment route
- Describe where the company, founders, customers and operating teams actually work.
- Identify the next financing milestone and the evidence already achieved.
- Match the product to the investor's published sector thesis and current stage.
- Confirm the specific manager, fund and founder-facing process before sharing sensitive material.
Compare 18 China investor routes
Use provider type, stage and geographic connection together. An office address is not a promise of eligibility. Where the current source does not establish a precise entry stage, the table leaves that question open.
Selected China-connected venture investors and one separately labeled accelerator, researched October 30, 2026. Confirm the present fund and company criteria directly. On small screens, scroll the table sideways to see every column.
| Investor or network | Provider type | Stage | Sector focus | Geographic connection |
|---|---|---|---|---|
| Vertex Ventures China | China venture fund team | Early-stage investments; fund-specific | Technology; advanced manufacturing; biomedicine | China team with Beijing, Shanghai and Shenzhen offices |
| Qiming Venture Partners | Venture investment manager | Early and growth stages | Technology and healthcare innovation | China venture investment platform |
| Ivy Capital | Deep-technology venture investor | Early investment with follow-on activity | AI infrastructure; advanced materials; photonics; other deep technology | Founded in Shanghai with Shanghai and Hong Kong context |
| Gobi China | Early-stage venture manager | Early stage; vehicle-specific | Technology businesses | China team based in Shanghai and Beijing |
| Linear Capital | Frontier-technology venture investor | Angel through Series A | AI software and hardware; science and manufacturing | China-linked technology investor with international examples |
| Jingwei Venture Capital | China venture investment manager | Early and early-growth stages | Software; technology; advanced manufacturing; consumer | China-focused strategy in its Chinese-language overview |
| Ince Capital | Early-to-expansion venture firm | Early through expansion | AI; technology; consumer; biotechnology | Shanghai, Beijing and Hong Kong offices |
| Soul Capital | Early-stage venture investor | Early stage | Technology startups | Explicit China-focused early-stage strategy |
| Lighthouse Yuanzhan Capital | Early-stage venture investor | Early stage | Technology products and commercialization | China-based manager with China and US startup activity |
| Long Venture Partners | Cross-border venture firm | Early stage | Fintech; enterprise; consumer internet; AI and data | Published China and US investment focus |
| Lingfeng Capital | Regional technology venture manager | Early through growth; vehicle-specific | Digital finance; industrial technology; AI and data | Greater China and ASEAN focus with other selective exposure |
| Next Capital | Early-stage venture investor | First investment and early stage | Technology startups; company-specific | Published founder-investment history includes China's technology market |
| Bits x Bites | Specialist agrifood venture investor | Early stage | Agriculture; food technology; bioscience; supply chains | Shanghai-based investor focused on food-system challenges in China |
| Eminence Ventures | Enterprise-cloud venture firm | Early stage | Enterprise software and cloud computing | Published China enterprise-cloud focus |
| XVC | Technology venture investor | Confirm current entry stage | Platforms; data-driven applications; company-specific technology | Beijing contact and China-linked portfolio examples |
| EdgeVentures | Venture investment firm | Angel through Series A emphasis; later participation varies | Internet; technology; consumer services | China-connected manager; verify the current fund's geographic remit |
| Intonation Ventures | Consumer-technology venture platform | China stage varies; US early-stage strategy is separate | Consumer technology; gaming; wellness; marketplaces | Describes a Beijing investment arm and China investment activity |
| MiraclePlus | Investment-backed accelerator | Early-stage cohort; terms and timing may change | Startup and technology companies | Early-stage accelerator for startups in China |
Distinguish a China team from a cross-border platform
Vertex identifies independently operated regional teams, while Lingfeng describes Greater China and ASEAN strategies. Intonation describes a Beijing arm alongside a separate North American approach. These are different organizational structures, not interchangeable invitations to every founder.
Record the relevant team, company operating market and open geography question. A prior investment or an office address is a lead for further research, not proof of eligibility.
Match a technical thesis to the product and evidence
Bits x Bites focuses on agrifood technology; Eminence describes enterprise software and cloud; Ivy and Linear emphasize frontier technologies. Qiming and Vertex describe technology and healthcare-related approaches.
Explain the actual user, technical result, customer evidence and next milestone before labeling the company as a sector fit. A general-purpose AI feature is not automatically a match for every deep-tech strategy.
Separate an investor from an accelerator
MiraclePlus combines an investment decision with a time-bound accelerator program. The program is one route in this directory, not a count of the mentors or outside investors who may attend its events.
For venture managers, identify the current fund and entry stage. Follow-on support for a portfolio company is not evidence that every new company can enter at the same later stage.
Turn the directory into a short research queue
Select a few candidates with a source-backed stage and thesis connection. Save the official page and date, note what remains unknown, and assign one next research action for each manager.
Use the manager's published founder route where available. Do not equate investor-relations or fund-subscription products with financing for your company.
Investor profiles and official routes
These profiles are a research aid, not a performance ranking. Read the current strategy and portfolio before sharing a deck. A public contact route does not establish that a firm has available allocation for your round.
Vertex Ventures China
China venture fund team. China team with Beijing, Shanghai and Shenzhen offices. Vertex describes independently operated regional fund teams. Select the China team and current vehicle rather than assuming every Vertex fund shares the same mandate.
Vertex Ventures China: official investment information
Qiming Venture Partners
Venture investment manager. China venture investment platform. Qiming's Chinese-language overview distinguishes technology and healthcare. Match the actual product and stage to the relevant team instead of assuming a portfolio company's later round defines initial entry.
Qiming Venture Partners: official investment information
Ivy Capital
Deep-technology venture investor. Founded in Shanghai with Shanghai and Hong Kong context. Ivy states an AI and deep-tech focus. Explain the technical evidence and commercial use case, then confirm the company's geographic and fund fit.
Ivy Capital: official investment information
Gobi China
Early-stage venture manager. China team based in Shanghai and Beijing. Gobi China describes China-based early-stage funds. Count the China manager once; a similarly named regional or Pakistan venture team is not automatically the same fund.
Gobi China: official investment information
Linear Capital
Frontier-technology venture investor. China-linked technology investor with international examples. Linear describes angel-to-Series-A investment and a frontier-technology focus. A past international portfolio company does not establish that every geography or company structure is eligible.
Linear Capital: official investment information
Jingwei Venture Capital
China venture investment manager. China-focused strategy in its Chinese-language overview. Jingwei's official overview describes early and early-growth investing in China. Confirm the relevant investment team and current route; historical brand associations are not separate investors.
Jingwei Venture Capital: official investment information
Ince Capital
Early-to-expansion venture firm. Shanghai, Beijing and Hong Kong offices. Ince lists early-to-expansion investment and several sector theses. An office address is a starting point for research, not evidence of an open fund or applicant eligibility.
Ince Capital: official investment information
Soul Capital
Early-stage venture investor. Explicit China-focused early-stage strategy. Soul's official English overview describes early-stage technology companies in China. Prepare the technical differentiation and the operating market before asking about the current vehicle.
Soul Capital: official investment information
Lighthouse Yuanzhan Capital
Early-stage venture investor. China-based manager with China and US startup activity. This is Lighthouse Yuanzhan Capital, not similarly named firms in other markets. Its published approach connects technology with commercialization; verify the current fund and founder route.
Lighthouse Yuanzhan Capital: official investment information
Long Venture Partners
Cross-border venture firm. Published China and US investment focus. Long's China and US descriptions address different market opportunities. Explain the actual customer market and operating connection rather than assuming that one office implies a universal mandate.
Long Venture Partners: official investment information
Lingfeng Capital
Regional technology venture manager. Greater China and ASEAN focus with other selective exposure. Lingfeng describes regional strategies and fund-management entities. Identify the team and vehicle that match the company; the regional platform is not a promise of investment in every location.
Lingfeng Capital: official investment information
Next Capital
Early-stage venture investor. Published founder-investment history includes China's technology market. Next Capital describes early investment and a founding partner's China technology experience. Its public site does not establish every current geography or sector, so confirm the specific mandate.
Next Capital: official investment information
Bits x Bites
Specialist agrifood venture investor. Shanghai-based investor focused on food-system challenges in China. Bits x Bites states an agrifood technology thesis. A general consumer-food brand should establish the technology and food-system connection before treating the fund as a match.
Bits x Bites: official investment information
Eminence Ventures
Enterprise-cloud venture firm. Published China enterprise-cloud focus. Eminence describes early-stage enterprise software and cloud investing in China. Separate actual business-customer use from a generic AI or software label.
Eminence Ventures: official investment information
XVC
Technology venture investor. Beijing contact and China-linked portfolio examples. XVC describes its investment thesis and a Beijing contact. Review the current team and stage rather than inferring an open allocation from a named portfolio company.
XVC: official investment information
EdgeVentures
Venture investment firm. China-connected manager; verify the current fund's geographic remit. EdgeVentures describes an angel-to-A emphasis and later participation. Confirm the current strategy directly because individual portfolio rounds do not establish a new applicant's entry stage.
EdgeVentures: official investment information
Intonation Ventures
Consumer-technology venture platform. Describes a Beijing investment arm and China investment activity. Intonation describes Borong Capital as its Beijing investment arm. Treat the platform and its arm as one research route here, not two independent committed investors.
Intonation Ventures: official investment information
MiraclePlus
Investment-backed accelerator. Early-stage accelerator for startups in China. MiraclePlus combines an accelerator with investment. The program, its mentors and subsequent demo-day investors are distinct; check the current cohort and terms before treating it as a fit.
MiraclePlus: official investment information
Worked example: an industrial AI startup
Illustrative example, not an investment recommendation. A fictional team has a software prototype that detects defects in factory images. One manufacturer is evaluating a pilot; there is no established recurring revenue. The team is documenting its China operating connection and next technical milestone.
Research questions for the fictional company
| Route | Why research it | Question to verify |
|---|---|---|
| Ivy or Linear | AI and frontier-technology theses | Does the technical advantage and stage fit the current fund? |
| Eminence | Enterprise software and cloud | Is the customer workflow and deployment model a fit? |
| Vertex China | Technology and advanced manufacturing | Which team and vehicle evaluate this company? |
| MiraclePlus | Investment-backed early-stage program | Does the current cohort fit the founders and desired support? |
| Bits x Bites | Specialist agrifood thesis | Hold unless the product has a real food-system application. |
No named organization has evaluated this fictional company.
Copy your China investor shortlist worksheet
Use one record for each investor and specific vehicle. Keep the source date beside your fit decision.
CHINA INVESTOR FIT CARD
Company, product and buyer: [facts I may share]
Founder, operating and customer markets: [actual connections]
Current proof: [research / prototype / pilot / revenue]
Next financing milestone: [specific evidence]
Manager and relevant fund or team: [name]
Entry stage and sector: [official source + date]
China or cross-border remit: [documented / confirm]
Founder process: [published route and open questions]
Related program or arm: [relationship, not a separate commitment]
Decision and next action: [research / ask / hold; owner and date]Research the shortlist with Aurora, Claude or Codex
Give your AI teammate company facts you are authorized to share. Ask for sourced comparisons and open questions, not automatic introductions or outreach.
Be my China-focused investor-research teammate.
Company, product and buyer: [facts I am authorized to share]
Founder, operating and customer markets: [actual connections]
Current evidence and next financing milestone: [facts]
Candidates: [selected managers and the relevant program]
Check current official sources for each team's stage, sector and geographic remit.
Distinguish China-specific funds, cross-border teams and accelerator programs.
Deduplicate related managers, funds and operating arms.
Return source/date, supported fit, unresolved questions and a next research action.
Do not invent funding availability, eligibility, check sizes or introductions.
Do not contact anyone, submit material or provide personalized legal or tax advice.Keep the resulting investor records, relationship context and next actions together in Finta. The investor-prospecting workflow covers the next execution step.
Methodology, research date and local guides
Research checked October 30, 2026 by the Finta Editorial Team with AI-assisted source review. We reviewed publicly available sources, including official strategy, portfolio, location, fund-backer or founder-contact information. Firms with multiple offices count once; angel networks count as networks, not one committed pooled fund. We distinguish local presence from investment mandate and company eligibility. We do not infer check sizes, investor returns, lead behavior or open allocation from a portfolio logo.
We reviewed official manager strategies and one accelerator's published program information. Some official sources are in Chinese; their strategy descriptions were interpreted for this guide. Managers are counted once even when they describe multiple funds or operating arms.
This is a selected research directory, not an exhaustive register or performance ranking. A China office, a portfolio example or a regional label does not establish the current fund's terms or a particular company's eligibility. Confirm the relevant team and process directly.
Informational purposes only. Finta is not a law firm or accounting firm. This is general fundraising information, not personalized financial, legal or tax advice. Discuss financing structures and tax matters with your attorney or accountant.
This is a selected research directory, not an exhaustive register or sponsored ranking. Confirm the current vehicle, team and process directly before relying on a fit decision.
Make the next fundraising step specific
Choose a small set of defensible matches, record the open question, and assign the next action. Use our investor-shortlist guide and warm-introduction guide to prepare the conversation. A longer list should make the research better, not turn into an indiscriminate mailing list.